Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06414083 · ClinicalTrials.gov registry record · NA

Histologic Comparison of Ablative Techniques for Endometriosis

A NA study of Endometriosis and Endometriosis-related Pain, sponsored by TriHealth.

Recruiting
Registry status
NA
Development phase
141
Enrollment target
1
Study location

NCT06414083 is a NA study of Endometriosis and Endometriosis-related Pain that is actively recruiting participants, run by TriHealth. The registered enrollment target is 141 participants, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06414083, a NA study of Endometriosis and Endometriosis-related Pain, is actively recruiting participants, sponsored by TriHealth.

RECRUITING
Registry status
NA
Development phase
141 participants
Enrollment target
1
Study location

Study Summary

To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.

Interventions

  • DEVICE CO2 Laser
  • DEVICE Diathermy
  • DEVICE Argon Beam Coagulator

Study Locations (1)

Ohio

  • Good Samaritan Hospital - Cincinnati

Trial Details

FieldValue
Enrollment Target 141 participants
Start Date 2024-05-09
Est. Completion 2025-06-09
Phase NA

Sponsor

TriHealth

81 total trials

What the Registry Record Tells You About NCT06414083

The ClinicalTrials.gov registry entry for NCT06414083 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (46% lower). The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Endometriosis appearing as the primary indexed condition, and to 3 interventions - of which CO2 Laser is the first listed.

NCT06414083 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06414083 about?

NCT06414083 is a clinical study titled "Histologic Comparison of Ablative Techniques for Endometriosis". To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.

What is the current status of trial NCT06414083?

This trial is currently recruiting. It is a NA study. The enrollment target is 141 participants. The study started on 2024-05-09. Estimated completion is 2025-06-09.

What conditions does trial NCT06414083 study?

This clinical trial studies the following conditions: Endometriosis, Endometriosis-related Pain, Endometriosis Pelvic, Endometriosis; Peritoneum.

What interventions are being tested in trial NCT06414083?

The interventions under investigation include: CO2 Laser (DEVICE), Diathermy (DEVICE), Argon Beam Coagulator (DEVICE).

Who is sponsoring clinical trial NCT06414083?

This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06414083 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometriosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.